UDENYCA® (pegfilgrastim-cbqv) Biosimilar
Quarterly Sales (Approved)
August 6, 2020
Amp Volatility Score
Catalyst Info & Data Links
TITLE: UDENYCA® (pegfilgrastim-cbqv) - Quarterly Sales
WHAT IS THE CATALYST EVENT?
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
05-07-2020 First Quarter 2020 Financial Results
MECHANISM OF ACTION / RATIONALE
Pegfilgrastim products are colony-stimulating factors that act on hematopoietic cells by binding to specific cell surface receptors, thereby stimulating proliferation, differentiation, commitment, and end cell functional activation.
source - FDA Label (section 12.1)
Updated by HC
#CHRS, #UDENYCA, #pegfilgrastim-cbqv
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post